If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mimma Rizzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors

Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Jan 2020, In : Cancers. 12, 1, 84.

Research output: Contribution to journalArticle

Open Access
  • Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers

    Rofi, E., Del Re, M., Arrigoni, E., Rizzo, M., Fontanelli, L., Crucitta, S., Gianfilippo, G., Restante, G., Fogli, S., Porta, C., Danesi, R. & Schmidinger, M., Dec 2019, In : Critical Reviews in Oncology/Hematology. 144, p. 102812

    Research output: Contribution to journalReview article

  • Immune-based combination therapy for metastatic kidney cancer

    Porta, C. & Rizzo, M., Jun 2019, In : Nature Reviews Nephrology. 15, 6, p. 324-325 2 p.

    Research output: Contribution to journalArticle

    Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

    Saltarella, I., Morabito, F., Giuliani, N., Terragna, C., Omedè, P., Palumbo, A., Bringhen, S., De Paoli, L., Martino, E., Larocca, A., Offidani, M., Patriarca, F., Nozzoli, C., Guglielmelli, T., Benevolo, G., Callea, V., Baldini, L., Grasso, M., Leonardi, G., Rizzo, M. & 9 others, Falcone, A. P., Gottardi, D., Montefusco, V., Musto, P., Petrucci, M. T., Dammacco, F., Boccadoro, M., Vacca, A. & Ria, R., 2019, In : Journal of Hematology and Oncology. 12, 1

    Research output: Contribution to journalArticle

  • Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

    Saltarella, I., Morabito, F., Giuliani, N., Terragna, C., Omedè, P., Palumbo, A., Bringhen, S., De Paoli, L., Martino, E., Larocca, A., Offidani, M., Patriarca, F., Nozzoli, C., Guglielmelli, T., Benevolo, G., Callea, V., Baldini, L., Grasso, M., Leonardi, G., Rizzo, M. & 9 others, Falcone, A. P., Gottardi, D., Montefusco, V., Musto, P., Petrucci, M. T., Dammacco, F., Boccadoro, M., Vacca, A. & Ria, R., 2019, In : Journal of Hematology and Oncology. 12, 1, 4.

    Research output: Contribution to journalArticle